$IMLFF Income Statement

InMed Pharmaceuticals Inc. (IMLFF)

Income Statement

Get Income Statement for:

View: Annual Data | Quarterly Data

All numbers in thousands

Period Ending		Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013
Total Revenue		–	–	–	–
Cost of Revenue		–	–	–	–

Gross Profit		–	–	–	–

	Operating Expenses
	Research Development	43	31	13	14
	Selling General and Administrative	513	986	78	22
	Non Recurring	–	–	–	–
	Others	27	–	–	–

	Total Operating Expenses	–	–	–	–


Operating Income or Loss		(584)	(1,017)	(91)	(36)

	Income from Continuing Operations
	Total Other Income/Expenses Net	0	(2)	(0)	1
	Earnings Before Interest And Taxes	(584)	(1,018)	(91)	(35)
	Interest Expense	–	–	–	–
	Income Before Tax	(584)	(1,018)	(91)	(35)
	Income Tax Expense	–	–	–	–
	Minority Interest	–	–	–	–

	Net Income From Continuing Ops	(584)	(1,017)	(91)	(35)

	Non-recurring Events
	Discontinued Operations	–	–	–	–
	Extraordinary Items	–	–	–	–
	Effect Of Accounting Changes	–	–	–	–
	Other Items	–	–	–	–


Net Income		(584)	(1,017)	(91)	(35)
Preferred Stock And Other Adjustments		–	–	–	–

Net Income Applicable To Common Shares		(584)	(1,017)	(91)	(35)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com